Press Release - Company Data

DiagnoCure Announces First Quarter 2014 Results
Posted 2014-03-14 02:32NAI Editing
today reported financial and operational results for the first quarter 2014 ended January 31, 2014.

Diagnocure Announces Resignation of CFO
Posted 2013-09-30 23:34NAI Editing
announced today that Ms. Chantal Miklosi has resigned her position as Chief Financial Officer of the Corporation effective October 11th. She will leave to pursue other career opportunities. Dr.

Diagnocure Grants Stock Options To Senior Advisor
Posted 2013-09-16 23:33NAI Editing
reports the granting, as of today, of 500,000 options to Richard Bordeleau who was appointed Senior Advisor to the Board on September 1st, 2013.

DiagnoCure Appoints Richard Bordeleau as Senior Advisor to the board
Posted 2013-08-20 00:00NAI Editing
a life sciences company developing and commercializing high‐value cancer diagnostic tests, today announced the appointment of Mr.

DiagnoCure Announces Second Quarter 2013 Results
Posted 2013-06-03 07:04NAI Editing
today reported financial and operational results for the second quarter ended April 30, 2013.

Data From a New Study on Diagnocure's GCC Assay Show Positive Results for Predicting Risk of Colon Cancer Recurrence
Posted 2013-06-02 23:30NAI Editing
today reported that results of a new study were presented on Sunday, June 2, during the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, Illinois.

DiagnoCure Directors Re-Elected by Shareholders at Annual and Special Meeting of Shareholders
Posted 2013-04-29 13:16NAI Editing
is pleased to announce that Dr. Yves Fradet, Dr. Louise Proulx, Mr. Andrew Sheldon, Dr. Jacques Simoneau, and Dr. Vincent R.

Nominations Pursuant to Advance Notice Policy
Posted 2013-04-15 00:30NAI Editing
Following the adoption by its Board of directors of an advance notice policy, DiagnoCure Inc.

DiagnoCure's Adoption of An Advance Notice Policy
Posted 2013-04-09 00:34NAI Editing
announces the adoption by its board of directors of an advance notice policy establishing conditions and framework to submit director nominations, similar to what is set forth in the advance notice by

DiagnoCure Joins the OTCQX Marketplace and S&P Corporation Records Listing
Posted 2013-04-02 00:35NAI Editing
today announced that the Company's stock is now trading on OTCQXInternational under the symbol "DGCRF". OTCQX is the best U.S.